ANN ARBOR, Mich., Sept. 1, 2011 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that company president and CEO Tim Mayleben will speak at the Stifel Nicolaus Healthcare Conference, which is being held September 7-9, 2011, at the Four Seasons Hotel in Boston, Massachusetts.
